AMCADOP-CV 325 – Cefpodoxime Proxetil 200 mg + Potassium Clavulanate 125 mg Tablets

AMCADOP-CV 325 by Amcare Biosciences is a prescription antibacterial combination containing Cefpodoxime Proxetil equivalent to Cefpodoxime 200 mg and Potassium Clavulanate equivalent to Clavulanic Acid 125 mg in each film-coated tablet. This combination is used for susceptible bacterial infections when considered appropriate by a qualified healthcare professional.

AMCADOP-CV 325 Composition

Each film-coated tablet of AMCADOP-CV 325 contains:

• Cefpodoxime Proxetil IP equivalent to Cefpodoxime – 200 mg
• Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid – 125 mg
• Excipients – q.s.

Brand Name: AMCADOP-CV 325
Generic Name: Cefpodoxime Proxetil + Potassium Clavulanate
Strength: Cefpodoxime 200 mg + Clavulanic Acid 125 mg
Dosage Form: Film-Coated Tablets
Therapeutic Category: Antibacterial / Antibiotic
Route of Administration: Oral
Pack Size: 10 × 1 × 10 Tablets
Company: Amcare Biosciences

AMCADOP-CV 325 Uses

AMCADOP-CV 325 is an antibacterial combination that may be prescribed for certain bacterial infections caused by susceptible organisms.

Depending on the clinical diagnosis, it may be used for:

• Respiratory tract bacterial infections
• Ear, nose and throat bacterial infections
• Urinary tract bacterial infections
• Skin and soft-tissue bacterial infections
• Other susceptible bacterial infections

The exact indication should be determined by the treating healthcare professional based on the patient’s condition and suspected or confirmed bacterial pathogen.

AMCADOP-CV 325 is not effective against viral infections such as the common cold or influenza.

AMCADOP-CV 325 Benefits

Key features of AMCADOP-CV 325 include:

• Contains Cefpodoxime 200 mg + Clavulanic Acid 125 mg
• Combines a third-generation cephalosporin antibiotic with a beta-lactamase inhibitor
• Helps extend the antibacterial activity of Cefpodoxime against certain beta-lactamase-producing bacteria
• Convenient oral film-coated tablet formulation
• Suitable for use when this antibiotic combination is clinically indicated
• Manufactured and marketed by Amcare Biosciences

How Does AMCADOP-CV 325 Work?

AMCADOP-CV 325 contains two active components: Cefpodoxime and Clavulanic Acid.

Cefpodoxime in AMCADOP-CV 325

Cefpodoxime is a third-generation cephalosporin antibiotic. It works by interfering with bacterial cell-wall synthesis, which inhibits the growth of susceptible bacteria.

Clavulanic Acid in AMCADOP-CV 325

Clavulanic acid is a beta-lactamase inhibitor. Some bacteria produce enzymes called beta-lactamases that can reduce the activity of certain beta-lactam antibiotics. Clavulanic acid inhibits some of these enzymes, helping protect Cefpodoxime from enzymatic degradation.

AMCADOP-CV 325 Combination

The combination of Cefpodoxime and Clavulanic Acid provides antibacterial activity against certain susceptible organisms, including some bacteria that produce beta-lactamase enzymes. The combination should be used only when clinically appropriate.

AMCADOP-CV 325 Dosage and Administration

The dosage and duration of AMCADOP-CV 325 should be determined by the prescribing doctor according to the type and severity of infection, patient’s age, kidney function and other clinical factors.

• Take AMCADOP-CV 325 exactly as prescribed.
• Swallow the tablet with water.
• Follow the dosing schedule recommended by your doctor.
• Do not exceed the prescribed dose.
• Complete the prescribed course unless your doctor advises otherwise.
• Do not self-medicate with antibiotics.

AMCADOP-CV 325 Side Effects

Some patients taking AMCADOP-CV 325 may experience:

• Nausea
• Vomiting
• Diarrhea
• Abdominal discomfort
• Indigestion
• Headache
• Skin rash

Seek medical attention if you develop signs of a serious allergic reaction, difficulty breathing, severe skin reactions or severe/persistent diarrhea.

AMCADOP-CV 325 Precautions and Warnings

Before taking AMCADOP-CV 325, inform your doctor if you:

• Are allergic to Cefpodoxime, cephalosporins or other beta-lactam antibiotics
• Have previously experienced an allergic reaction to penicillins
• Have kidney problems
• Have a history of antibiotic-associated diarrhea
• Have liver problems
• Are taking other prescription or non-prescription medicines
• Are pregnant, planning pregnancy or breastfeeding

Use AMCADOP-CV 325 only under medical supervision. Do not share antibiotics or use leftover antibiotics from previous treatments.

AMCADOP-CV 325 Storage

Store AMCADOP-CV 325 according to the instructions provided on the product packaging.

• Store in a dry place.
• Protect from moisture.
• Keep away from excessive heat.
• Keep out of direct sunlight.
• Keep out of reach of children.
• Keep the tablets in their original packaging.

Why Choose AMCADOP-CV 325 by Amcare Biosciences?

AMCADOP-CV 325 is part of the pharmaceutical product portfolio of Amcare Biosciences. The company operates across pharmaceutical, Ayurvedic, nutraceutical and cosmetic product segments and serves domestic and international business requirements.

AMCADOP-CV 325 provides a combination of Cefpodoxime 200 mg and Clavulanic Acid 125 mg in a convenient film-coated tablet formulation for use when this combination is considered appropriate by a healthcare professional.